Machine Learning to Predict Postoperative Pneumonia in Brain Tumor Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1856 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative pneumonia (POP) is a common and serious complication after elective craniotomy for brain tumor resection. POP often develops within the first week after surgery and may lead to prolonged hospitalization, higher medical costs, and increased risk of severe illness. Because symptoms can be subtle in neurosurgical patients, POP may be detected late, limiting timely prevention and treatment.

This study will evaluate whether a machine-learning-based clinical decision support tool can help clinicians identify patients at high risk for POP early and improve perioperative preventive care. The tool uses routinely collected clinical information to estimate an individual patient's POP risk and provides an easy-to-understand explanation of key risk drivers. Based on the predicted risk level (low, moderate, high, or very high), the system suggests standardized preventive care pathways (e.g., perioperative airway management, targeted antibiotic strategies per local practice, and nutritional support), while allowing clinicians to override recommendations at any time.

Participants will be adults undergoing their first elective craniotomy for brain tumor resection at participating neurosurgical centers. The primary outcome is the occurrence of POP within 7 days after surgery, defined using CDC/NHSN criteria. Secondary outcomes include antibiotic use intensity, length of hospital stay, direct medical cost, and clinician decision confidence. Participants will be followed at postoperative days 1, 3, and 7 using electronic medical record review and phone confirmation when needed.

The goal of this study is to determine whether integrating an explainable AI risk prediction tool into routine care can reduce POP and improve the quality and efficiency of perioperative management after brain tumor surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

AI Models for Predicting Occult Pleural Dissemination in NSCLC

NCT07065422

Non-Small Cell Lung Cancer

COMPLETED

Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

NCT07059923

Lung Cancer (Diagnosis)

RECRUITING

Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors

NCT06737367

Lung Cancer - Non Small Cell

COMPLETED

Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer

NCT07107035

AI (Artificial Intelligence) NSCLC Brain Metastasis

NOT_YET_RECRUITING

Postoperative Pulmonary Function Assessment Based on Deep Learning Study

NCT07256457

Lung Cancer (NSCLC)

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale Postoperative pneumonia (POP) remains a frequent and clinically important complication after elective craniotomy for brain tumor resection, contributing to prolonged hospitalization, increased cost, and worse clinical outcomes. Conventional POP risk assessment is often experience-based or relies on simplified scoring approaches, which may not adequately capture nonlinear interactions among perioperative factors. This study implements an explainable machine-learning (ML) prediction model within routine perioperative workflows and evaluates whether model-assisted care can improve POP prevention and related resource utilization compared with usual care.

Decision support system

An explainable gradient boosting machine (GBM) model is used to estimate individual POP risk from routinely available perioperative variables. Interpretability is provided using SHAP-based explanations at two complementary levels:

Population level: summarizes the most influential predictors and selected interaction patterns to support clinical understanding and model governance.

Patient level: generates an individualized contribution visualization (e.g., waterfall-style), highlighting the main drivers of a specific patient's risk estimate.

The system automatically assigns a risk tier (low, moderate, high, or very high) and links each tier to standardized prevention pathway templates (e.g., airway management optimization, antimicrobial stewardship-consistent strategies per local policy, and nutritional support). The tool does not mandate treatment; clinicians may accept, modify, or override any suggestion.

Evaluation framework The overall project includes retrospective model development/optimization, prospective external validation/calibration, and a pragmatic implementation evaluation. The registered interventional evaluation uses a multicenter, cluster randomized crossover design with monthly alternating periods of model-assisted care versus usual care. Allocation procedures, eligibility criteria, planned enrollment, and endpoint definitions/time windows are specified in the corresponding record modules (Study Design, Arms/Interventions, Outcome Measures, and Eligibility) to avoid duplication in this section.

Implementation and integration The model is deployed as a lightweight web service with unified APIs and data-exchange formats to enable non-disruptive integration with hospital information systems (HIS) and electronic medical records (EMR). A web-based front end and a Python-based back end support RESTful calls and are designed for low-latency inference (target single-prediction latency \<200 ms), suitable for perioperative and inpatient workflows.

Data governance and model updating To support long-term generalizability across hospitals and mitigate dataset shift, the project establishes a closed-loop maintenance process ("local de-identification → cloud retraining → model version management → edge deployment"). Model updates are version-controlled and deployed under governance procedures consistent with local regulations, institutional policies, and applicable ethics approvals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pneumonia Brain Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retrospective model development cohort (CAMS/PUMC, 2022-2024)

Retrospective cohort collected at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS/PUMC) between Jan 1, 2022 and Oct 31, 2024. Adult patients undergoing elective craniotomy for intracranial brain tumor resection were included. This cohort was used for model development, comparison of candidate algorithms, and internal validation; it was randomly split 8:2 into a training set (n=609) and an internal validation set (n=152). Early postoperative pneumonia (POP) was defined by CDC criteria within 7 days postoperatively. No study-mandated intervention was applied; routine perioperative care was provided.